HGCSG 1301: A multicenter, double-blind, randomized controlled phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer treated with IRIS/Bev as secondline therapy-Updated analysis of antitumor efficacy

Authors
Category Primary study
JournalJournal of clinical oncology
Year 2020
This article has no abstract
Epistemonikos ID: 86dac263f0d3cf6780415d68342be59331d77f2c
First added on: Feb 01, 2023